Clinical Trials Recruiting near Birmingham, AL

817 clinical trials have a recruiting site within 25 miles of Birmingham, Alabama, according to ClinicalTrials.gov data processed . The closest recruiting site is within 1 mile of the city center.
Distances are measured from the city center to each site's city, so they are approximate.
Recruiting now
Studies enrolling near Birmingham
Showing 30 studies, nearest first.
- A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
NCT07144280
- Phase 3
- Ages 18 years and older
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 10 sites within 25 mi
- MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
NCT03072927
- Observational
- Ages 18 years and older
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 8 sites within 25 mi
- A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
NCT05208762
- Phase 1
- Ages 18 years and older
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 4 sites within 25 mi
- A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
NCT06866405
- Phase 3
- Ages 0 years and older
- Sex: All
- Accepts healthy volunteers
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 4 sites within 25 mi
- BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
NCT07160244
- Phase 3
- Ages 1 day to 49 years
- Sex: All
- Accepts healthy volunteers
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 4 sites within 25 mi
- A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
NCT07206225
- Phase 1
- Ages 18 years and older
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 4 sites within 25 mi
- A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
NCT06873945
- Phase 3
- Ages 12 years and older
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 3 sites within 25 mi
- Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
NCT04088071
- Observational
- Ages 18 years and older
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama
NCT04093388
- Interventional
- Ages 21 to 65 years
- Sex: Female
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
NCT04262206
- Phase 4
- Ages 75 years and older
- Sex: All
- Accepts healthy volunteers
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- A Randomized Trial to Evaluate Sequential vs Simultaneous Patching
NCT04378790
- Phase 3
- Ages 3 to 13 years
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials
NCT05338697
- Observational
- Ages 18 years and older
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
NCT05624996
- Phase 3
- Ages 18 years and older
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
NCT05712200
- Phase 3
- Ages 65 years and older
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
NCT05946213
- Phase 3
- Ages 18 years and older
- Sex: Male
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- Refining Treatment Options for Trichomonas Vaginalis Infection: A Comparative Analysis of Metronidazole and Secnidazole
NCT06261840
- Phase 4
- Ages 18 years and older
- Sex: All
- Accepts healthy volunteers
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
NCT06419374
- Phase 3
- Ages 18 to 75 years
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
NCT06513962
- Phase 3
- Ages Up to 39 years
- Sex: Female
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
NCT06562543
- Phase 4
- Ages 18 years and older
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
NCT06677060
- Phase 3
- Ages 40 years and older
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
NCT06947993
- Phase 2
- Ages 18 to 100 years
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
NCT06989437
- Phase 2/3
- Ages 18 years and older
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
NCT07000357
- Phase 3
- Ages 18 years and older
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
NCT07136012
- Phase 3
- Ages 50 to 105 years
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
NCT07142356
- Phase 2
- Ages 18 to 75 years
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
NCT07143669
- Observational
- Ages 18 years and older
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
NCT07181109
- Phase 3
- Ages 18 years and older
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
NCT07231419
- Phase 3
- Ages 18 to 80 years
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
By condition
Clinical trials in Birmingham by condition
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.